These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 25102258
1. Nick Hales Award Lecture 2011: glucocorticoids and early life programming of cardiometabolic disease. Reynolds RM. J Dev Orig Health Dis; 2012 Oct; 3(5):309-14. PubMed ID: 25102258 [Abstract] [Full Text] [Related]
2. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner. Reynolds RM. Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948 [Abstract] [Full Text] [Related]
3. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Seckl JR, Cleasby M, Nyirenda MJ. Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076 [Abstract] [Full Text] [Related]
9. Glucocorticoid "programming" and PTSD risk. Seckl JR, Meaney MJ. Ann N Y Acad Sci; 2006 Jul; 1071():351-78. PubMed ID: 16891583 [Abstract] [Full Text] [Related]
10. Impact of maternal steroids during pregnancy. Reynolds RM. Ann Endocrinol (Paris); 2016 Dec; 77(6):677-679. PubMed ID: 27646492 [Abstract] [Full Text] [Related]
11. Placental 11β-HSD2 and Cardiometabolic Health Indicators in Infancy. Chen L, Guilmette J, Luo ZC, Cloutier A, Wang WJ, Yang MN, Fraser WD, Dubois J, Nuyt AM. Diabetes Care; 2019 May; 42(5):964-971. PubMed ID: 30833369 [Abstract] [Full Text] [Related]
12. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review. Carpenter T, Grecian SM, Reynolds RM. J Dev Orig Health Dis; 2017 Apr; 8(2):244-255. PubMed ID: 28103963 [Abstract] [Full Text] [Related]
13. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Seckl JR. Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721 [Abstract] [Full Text] [Related]
14. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism. Börzsönyi B, Demendi C, Pajor A, Rigó J, Marosi K, Agota A, Nagy ZB, Joó JG. Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940 [Abstract] [Full Text] [Related]
15. The Role of 11β-Hydroxy Steroid Dehydrogenase Type 2 in Glucocorticoid Programming of Affective and Cognitive Behaviours. Shearer FJG, Wyrwoll CS, Holmes MC. Neuroendocrinology; 2019 Mar; 109(3):257-265. PubMed ID: 30884491 [Abstract] [Full Text] [Related]
17. Glucocorticoids, prenatal stress and the programming of disease. Harris A, Seckl J. Horm Behav; 2011 Mar; 59(3):279-89. PubMed ID: 20591431 [Abstract] [Full Text] [Related]
18. Stress, glucocorticoids and liquorice in human pregnancy: programmers of the offspring brain. Räikkönen K, Seckl JR, Pesonen AK, Simons A, Van den Bergh BR. Stress; 2011 Nov; 14(6):590-603. PubMed ID: 21875300 [Abstract] [Full Text] [Related]
19. Maternal undernutrition and fetal developmental programming of obesity: the glucocorticoid connection. Correia-Branco A, Keating E, Martel F. Reprod Sci; 2015 Feb; 22(2):138-45. PubMed ID: 25001018 [Abstract] [Full Text] [Related]
20. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Jansson T, Powell TL. Clin Sci (Lond); 2007 Jul; 113(1):1-13. PubMed ID: 17536998 [Abstract] [Full Text] [Related] Page: [Next] [New Search]